These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

895 related items for PubMed ID: 32910747

  • 1. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
    Song XZ, Ren XN, Xu XJ, Ruan XX, Wang YL, Yao TT.
    Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. LncRNA RHPN1-AS1 accelerates proliferation, migration, and invasion via regulating miR-485-5p/BSG axis in hepatocellular carcinoma.
    Zhang W, Han L, Xing P, Liu B, Sun Z, Zhou W, Dong J.
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2543-2551. PubMed ID: 32435875
    [Abstract] [Full Text] [Related]

  • 4. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z, Wang Y, Wang L, Yao B, Sun L, Liu R, Chen T, Niu Y, Tu K, Liu Q.
    J Exp Clin Cancer Res; 2019 May 14; 38(1):194. PubMed ID: 31088485
    [Abstract] [Full Text] [Related]

  • 5. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.
    Fen H, Hongmin Z, Wei W, Chao Y, Yang Y, Bei L, Zhihua S.
    Curr Pharm Des; 2020 May 14; 25(43):4630-4640. PubMed ID: 31692433
    [Abstract] [Full Text] [Related]

  • 6. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
    Dong H, Jian P, Yu M, Wang L.
    J Cell Physiol; 2020 Oct 14; 235(10):6548-6562. PubMed ID: 32068261
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
    Guo X, Wang Y.
    Cancer Med; 2020 Jul 14; 9(14):5235-5246. PubMed ID: 32462698
    [Abstract] [Full Text] [Related]

  • 9. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH, Yu B, Chen WX, Ai X, Zhang W, Dong W, Shao YJ.
    Aging (Albany NY); 2021 Aug 02; 13(15):19260-19271. PubMed ID: 34341185
    [Abstract] [Full Text] [Related]

  • 10. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J, Dai C, Yu X, Yin XB, Zhou F.
    J Cell Biochem; 2021 Jan 02; 122(1):86-99. PubMed ID: 32786108
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T, Chen H, Wang P, Yang N, Bao J.
    Cancer Biother Radiopharm; 2020 Nov 02; 35(9):661-672. PubMed ID: 32275162
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
    Huang C, Li K, Huang R, Zhu J, Yang J.
    Life Sci; 2021 Feb 15; 267():118928. PubMed ID: 33358902
    [Abstract] [Full Text] [Related]

  • 14. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis.
    Huang Y, Xiang B, Liu Y, Wang Y, Kan H.
    Cancer Lett; 2018 Nov 28; 437():56-66. PubMed ID: 30165194
    [Abstract] [Full Text] [Related]

  • 15. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H, Wang Y, Ye P, Yi D, Cheng Y, Tang H, Zhu Z, Wang X, Jin S.
    J Exp Clin Cancer Res; 2020 Aug 14; 39(1):159. PubMed ID: 32795316
    [Abstract] [Full Text] [Related]

  • 16. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K.
    Mol Cancer; 2019 Feb 19; 18(1):28. PubMed ID: 30782188
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
    Feng Y, Wei G, Zhang L, Zhou H, Wang W, Guo P, Cheng C, Ji L, Cai Q, Feng Y, Tu H.
    Bioengineered; 2021 Dec 19; 12(1):8217-8232. PubMed ID: 34596006
    [Abstract] [Full Text] [Related]

  • 20. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y, Wei Z, Huang M, Xu G, Wei W, Peng B, Nong S, Qin H.
    J Cell Mol Med; 2020 Jan 19; 24(2):1848-1865. PubMed ID: 31880390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.